[An update on human ehrlichiosis].
Human ehrlichiosis is a potentially lethal infections due to a new gram-negative microorganism. The first human case was reported in 1953 in Japan. Two of the animal agents are involved in human disease: Ehrlichia chaffeensis, Ehrlichia sennetsu. A third Ehrlichia type agent causes the disease in human beings only--Ehrlichia granulocytophila. The tick is natural vector; the highest frequency was observed in May-July, in the United States; the most important clinical signs are: fever, anorexia, rush, dyspnea etc.; the specific treatment consists in tetracycline administration (doxycycline minocycline) for up to seven days.
Corcaci
D C
DC
Clinica de Boli Infecţioase, Facultatea de Medicină, Universitatea de Medicină Gr. T. Popa, Iaşi.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D018469:Ehrlichia chaffeensis; D016873:Ehrlichiosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology*; D006801:Humans
D000900:Anti-Bacterial Agents